Latest filing published 15 Sept 2025 for Phio Pharmaceuticals Corp..
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Robert L. Ferrara is a declared insider of Phio Pharmaceuticals Corp. (board member), with filings sourced from SEC (Form 4). In total, 13 filings cover trades dated from 18 November 2019 to 11 September 2025.
The open-market record is one-sided, with 6 purchases worth €20k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants. Since January 2025: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €2,985. Of 6 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 15 September 2025 with a share grant in Phio Pharmaceuticals Corp. The last insider purchase was made public on 11 June 2025, 499 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations